Gossamer Bio, Inc. Common Stock (GOSS) is a publicly traded Healthcare sector company. As of October 23, 2026, GOSS trades at $9.44 with a market cap of $59.88M and a P/E ratio of -41.62. GOSS moved -3.58% today. Year to date, GOSS is -95.68%; over the trailing twelve months it is -94.65%. Its 52-week range spans $8.29 to $309.60. Analyst consensus is buy with an average price target of $86.48. Rallies surfaces GOSS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Gossamer Bio, Inc. Common Stock (GOSS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GOSS moved -3.58% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $9.44 |
| Market Cap | $59.88M |
| P/E Ratio | -41.62 |
| EPS | $-0.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $309.60 |
| 52-Week Low | $8.29 |
| Volume | 168.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $114.70M |
| Net Income | $-56.53M |
| Gross Margin | 0.00% |
6 analysts cover GOSS: 0 strong buy, 3 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $86.48.